DaVita (NYSE:DVA) Reaches New 52-Week Low – Here’s What Happened

Shares of DaVita Inc. (NYSE:DVA) reached a new 52-week low during trading on Wednesday . The company traded as low as $113.12 and last traded at $113.5920, with a volume of 38268 shares traded. The stock had previously closed at $114.72.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on DVA. Wall Street Zen lowered shares of DaVita from a “buy” rating to a “hold” rating in a research report on Saturday, October 11th. Zacks Research raised shares of DaVita from a “strong sell” rating to a “hold” rating in a report on Friday, November 28th. Cowen restated a “hold” rating on shares of DaVita in a report on Monday, November 3rd. UBS Group reiterated a “buy” rating on shares of DaVita in a research note on Monday, December 15th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of DaVita in a research note on Monday. One analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $148.00.

DaVita Stock Up 0.0%

The firm has a market capitalization of $8.10 billion, a P/E ratio of 11.82, a PEG ratio of 0.86 and a beta of 1.00. The firm has a 50 day moving average of $120.56 and a 200-day moving average of $130.87.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $2.51 EPS for the quarter, missing analysts’ consensus estimates of $3.17 by ($0.66). The company had revenue of $3.42 billion for the quarter, compared to the consensus estimate of $3.43 billion. DaVita had a negative return on equity of 13,370.89% and a net margin of 5.80%.DaVita’s revenue was up 4.8% on a year-over-year basis. During the same quarter last year, the business earned $2.59 EPS. DaVita has set its FY 2025 guidance at 10.350-11.150 EPS. As a group, research analysts expect that DaVita Inc. will post 10.76 EPS for the current year.

Institutional Investors Weigh In On DaVita

Several institutional investors and hedge funds have recently bought and sold shares of the company. Hantz Financial Services Inc. increased its holdings in DaVita by 48.1% in the 2nd quarter. Hantz Financial Services Inc. now owns 231 shares of the company’s stock valued at $33,000 after buying an additional 75 shares during the period. Mid American Wealth Advisory Group Inc. acquired a new stake in shares of DaVita during the 2nd quarter worth approximately $36,000. Canada Pension Plan Investment Board bought a new position in DaVita in the second quarter valued at approximately $43,000. Ameritas Advisory Services LLC acquired a new position in DaVita during the second quarter valued at approximately $47,000. Finally, Employees Retirement System of Texas acquired a new position in DaVita during the second quarter valued at approximately $49,000. Institutional investors own 90.12% of the company’s stock.

About DaVita

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.